Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis

Grzegorz Styczynski1, Piotr Kalinowski2, Łukasz Michałowski3

  • 1Department of Internal Medicine, Hypertension and Angiology Medical University of Warsaw Poland.

Insights

Patients with nonalcoholic steatohepatitis (NASH) and obesity show left ventricular remodeling and hyperdynamic circulation. This increased cardiac output in NASH may elevate cardiovascular event risk in this population.

Area of Science:

  • Cardiology
  • Hepatology
  • Obesity Medicine

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is linked to increased cardiovascular risk.
  • Liver abnormalities are suspected contributors to cardiac dysfunction in NAFLD patients.
  • Morbidly obese patients undergoing bariatric surgery represent a high-risk group for NAFLD and cardiovascular disease.

Purpose of the Study:

  • To investigate cardiac morphology and function in morbidly obese patients.
  • To compare cardiac parameters based on liver biopsy findings (NASH, isolated steatosis, no steatosis).
  • To assess the impact of nonalcoholic steatohepatitis on cardiovascular health in extreme obesity.

Main Methods:

  • Echocardiography was performed on 171 morbidly obese patients without known cardiac disease.
  • Patients were categorized based on liver biopsy results: 44 with NASH, 69 with isolated steatosis, and 58 without steatosis.
  • Cardiac morphology and function, including left ventricular remodeling and cardiac output, were evaluated.

Main Results:

  • Patients with NASH exhibited left ventricular concentric remodeling and hyperdynamic circulation compared to other groups.
  • Indexed left ventricular end-diastolic diameter and relative wall thickness were significantly different in the NASH group.
  • Cardiac index was significantly higher in patients with NASH (3.05 L/m²) versus isolated steatosis (2.80 L/m²) and no steatosis (2.79 L/m²).

Conclusions:

  • Nonalcoholic steatohepatitis is associated with left ventricular concentric remodeling and hyperdynamic circulation in extremely obese patients.
  • Elevated cardiac output in NASH patients may be an additional risk factor for cardiovascular events.
  • Further research is needed to elucidate the mechanisms linking NASH, obesity, and cardiovascular outcomes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
104
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
160
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
101